Mar 17, 2023 6:47am EDT NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
Mar 9, 2023 6:47am EST NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering
